SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-23-250741
Filing Date
2023-10-04
Accepted
2023-10-04 16:19:00
Documents
3
Group Members
CHENG YEE WING BETTYCHEUNG KA HOFRANCES ANNE ELIZABETH RICHARDJILL MARIE FRANKLINMVIL, LLCPETER STUART ALLENBY EDWARDSWONG SEE WAI

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d426014dsc13da.htm SC 13D/A 167997
2 EX-99.1 d426014dex991.htm EX-99.1 8980
3 EX-99.2 d426014dex992.htm EX-99.2 454835
  Complete submission text file 0001193125-23-250741.txt   633589
Mailing Address MCCARTHY LEGAL SERVICES 1188 CENTRE STREET NEWTON CENTRE MA 02459
Business Address MCCARTHY LEGAL SERVICES 1188 CENTRE STREET NEWTON CENTRE MA 02459 617-244-2800
Morningside Venture Investments Ltd (Filed by) CIK: 0001543112 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Subject) CIK: 0001658551 (see all company filings)

IRS No.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-93265 | Film No.: 231308169
SIC: 2834 Pharmaceutical Preparations